Julien Poublanc
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Julien Poublanc has a total of 113 co-authors. Here are the top co-authors by number of shared publications:
- David John Mikulis
Joint Department of Medical Imaging and the Functional Neuroimaging Lab, University Health Network, Toronto, Ontario, Canada (J.P., D.J.M., O.S.).
17 shared publications - Joseph Arnold Fisher
University of Toronto
15 shared publications - Olivia Sobczyk
Department of Anaesthesia and Pain Management, University Health Network, University of Toronto, Toronto, ON, Canada
14 shared publications - James Duffin
Department of Physiology University of Toronto Toronto Ontario Canada
13 shared publications - Ece Su Sayin
Department of Physiology, University of Toronto
9 shared publications - Adrian Philip Crawley
Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada
5 shared publications
Latest Publications
- 19 November 2025
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (5) , 1367-1372
Persistent Steal Physiology during a Ramp Cerebrovascular Reactivity Assessment Correlates with Severe Cortical Thinning in Steno-Occlusive Disease
BACKGROUND AND PURPOSE: Steal physiology, a marker of severe cerebrovascular impairment, is associated with cortical thinning, a morphological phenomenon seen in patients with chronic supply artery steno-occlusive disease. This link has been previously established only with a sudden “step” hypercapnic stimulus. The significance of steal patterns derived from a gradual “ramp” stimulus, and their association with structural brain injury, is unclear. We investigated how steal patterns derived from both step and ramp stimuli compare and relate to the severity of cortical thinning in patients with steno-occlusive disease. MATERIALS AND METHODS: Thirty-two patients with unilateral cortical steal, characterized by an asymmetric paradoxical reduction in blood flow during vasodilatory stimuli due to impaired vascular reserve in one hemisphere, were retrospectively identified from a prospectively maintained database. Cerebrovascular reactivity (CVR) was mapped using BOLD MRI during sequential step and ramp CO2 stimuli from a sequential gas delivery system. The spatial extent of cortical steal (volume with negative CVR) was quantified and correlated with inter-hemispheric cortical thickness differences for each stimulus type. RESULTS: The spatial extent of cortical steal physiology derived from the ramp stimulus was consistently smaller, averaging 81% of that seen with the step stimulus (p=0.004). Both stimulus approaches demonstrated significant correlations with cortical thinning (step: r=0.56, p<0.001; ramp: r=0.49, p=0.004). Patients exhibiting steal during both stimulus types showed more pronounced cortical thinning compared to those demonstrating steal only during step stimuli, suggesting that persistent steal across both protocols indicates more severe cerebrovascular impairment. CONCLUSIONS: The persistence of steal physiology seen during a gradual ramp stimulus reveals a more serious hemodynamic impairment than steal observed only during a sudden step challenge in patients with steno-occlusive disease. While the step stimulus is highly sensitive, its greater spatial extent of steal includes all hemodynamically vulnerable tissues, even those with slower but potentially effective collateral responses. The ramp stimulus gives these tissues more time for vascular response to evolve fully, thereby isolating persistent steal that represents complete failure of collateral circulation. This failed adaptation is associated with more severe structural brain injury. Therefore, multi-stimulus CVR protocols may offer a more nuanced approach to risk stratification. ABBREVIATIONS: BOLD=blood-oxygen-level-dependent; CVR=cerebrovascular reactivity.
- 19 November 2025
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (5) , 1367-1372
Persistent Steal Physiology during a Ramp Cerebrovascular Reactivity Assessment Correlates with Severe Cortical Thinning in Steno-Occlusive Disease
BACKGROUND AND PURPOSE: Steal physiology, a marker of severe cerebrovascular impairment, is associated with cortical thinning, a morphological phenomenon seen in patients with chronic supply artery steno-occlusive disease. This link has been previously established only with a sudden “step” hypercapnic stimulus. The significance of steal patterns derived from a gradual “ramp” stimulus, and their association with structural brain injury, is unclear. We investigated how steal patterns derived from both step and ramp stimuli compare and relate to the severity of cortical thinning in patients with steno-occlusive disease. MATERIALS AND METHODS: Thirty-two patients with unilateral cortical steal, characterized by an asymmetric paradoxical reduction in blood flow during vasodilatory stimuli due to impaired vascular reserve in one hemisphere, were retrospectively identified from a prospectively maintained database. Cerebrovascular reactivity (CVR) was mapped using BOLD MRI during sequential step and ramp CO2 stimuli from a sequential gas delivery system. The spatial extent of cortical steal (volume with negative CVR) was quantified and correlated with inter-hemispheric cortical thickness differences for each stimulus type. RESULTS: The spatial extent of cortical steal physiology derived from the ramp stimulus was consistently smaller, averaging 81% of that seen with the step stimulus (p=0.004). Both stimulus approaches demonstrated significant correlations with cortical thinning (step: r=0.56, p<0.001; ramp: r=0.49, p=0.004). Patients exhibiting steal during both stimulus types showed more pronounced cortical thinning compared to those demonstrating steal only during step stimuli, suggesting that persistent steal across both protocols indicates more severe cerebrovascular impairment. CONCLUSIONS: The persistence of steal physiology seen during a gradual ramp stimulus reveals a more serious hemodynamic impairment than steal observed only during a sudden step challenge in patients with steno-occlusive disease. While the step stimulus is highly sensitive, its greater spatial extent of steal includes all hemodynamically vulnerable tissues, even those with slower but potentially effective collateral responses. The ramp stimulus gives these tissues more time for vascular response to evolve fully, thereby isolating persistent steal that represents complete failure of collateral circulation. This failed adaptation is associated with more severe structural brain injury. Therefore, multi-stimulus CVR protocols may offer a more nuanced approach to risk stratification. ABBREVIATIONS: BOLD=blood-oxygen-level-dependent; CVR=cerebrovascular reactivity.
- 1 October 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (10) , 3034-3046
MRI-Based Classification of Cerebral Hemodynamic Failure With Resting Perfusion Metrics and Cerebrovascular Reactivity
BACKGROUND: The inability to augment regional cerebral blood flow (CBF) in the setting of steno-occlusive disease involving large brain-supplying arteries is a risk factor for stroke. The gold standard for detecting such hemodynamic impairment requires the application of a vasodilatory stimulus while measuring changes in CBF. Resting blood flow metrics derived from computed tomography or magnetic resonance imaging (MRI) perfusion methods have been applied as surrogates for assessing hemodynamic insufficiency including relative CBF, relative cerebral blood volume, and mean transit time (MTT). The purpose of this study, therefore, was to compare the sensitivity and specificity of MRI resting perfusion metrics with cerebrovascular reactivity (CVR). MRI CVR mapping was used as a reference standard for comparing MRI perfusion–derived CBF, CBV, and MTT. METHODS: MRI resting perfusion metrics were measured using a recently reported noninvasive method that induces a bolus of hypoxia-induced deoxyhemoglobin as the dynamic susceptibility contrast in place of the gadolinium-based contrast agents. CVR was measured using a standardized hypercapnic vasoactive stimulus during blood oxygen level–dependent MRI as a surrogate for CBF. RESULTS: Twenty-two patients with large artery steno-occlusive disease (mean age±SD, 46±17.8 years; 60% female), 24 healthy participants for the CVR atlas (35.1±13.8 years; 33% female), and 25 for the perfusion atlas (38.4±17.6 years; 24% female) were recruited. Significant differences in mean hemispheric middle cerebral artery perfusion (MTT, relative CBF) and CVR metrics in gray matter ( P P <0.05). Receiver-operating characteristic curves identified CVR as the most sensitive predictor for hemodynamic impairment followed by MTT. CONCLUSIONS: CVR remains a more accurate test for assessing hemodynamic impairment compared to resting blood flow metrics.
- 1 October 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (10) , 3034-3046
MRI-Based Classification of Cerebral Hemodynamic Failure With Resting Perfusion Metrics and Cerebrovascular Reactivity
BACKGROUND: The inability to augment regional cerebral blood flow (CBF) in the setting of steno-occlusive disease involving large brain-supplying arteries is a risk factor for stroke. The gold standard for detecting such hemodynamic impairment requires the application of a vasodilatory stimulus while measuring changes in CBF. Resting blood flow metrics derived from computed tomography or magnetic resonance imaging (MRI) perfusion methods have been applied as surrogates for assessing hemodynamic insufficiency including relative CBF, relative cerebral blood volume, and mean transit time (MTT). The purpose of this study, therefore, was to compare the sensitivity and specificity of MRI resting perfusion metrics with cerebrovascular reactivity (CVR). MRI CVR mapping was used as a reference standard for comparing MRI perfusion–derived CBF, CBV, and MTT. METHODS: MRI resting perfusion metrics were measured using a recently reported noninvasive method that induces a bolus of hypoxia-induced deoxyhemoglobin as the dynamic susceptibility contrast in place of the gadolinium-based contrast agents. CVR was measured using a standardized hypercapnic vasoactive stimulus during blood oxygen level–dependent MRI as a surrogate for CBF. RESULTS: Twenty-two patients with large artery steno-occlusive disease (mean age±SD, 46±17.8 years; 60% female), 24 healthy participants for the CVR atlas (35.1±13.8 years; 33% female), and 25 for the perfusion atlas (38.4±17.6 years; 24% female) were recruited. Significant differences in mean hemispheric middle cerebral artery perfusion (MTT, relative CBF) and CVR metrics in gray matter ( P P <0.05). Receiver-operating characteristic curves identified CVR as the most sensitive predictor for hemodynamic impairment followed by MTT. CONCLUSIONS: CVR remains a more accurate test for assessing hemodynamic impairment compared to resting blood flow metrics.
- Open Access
Cerebral perfusion metrics calculated directly, model-free, from a hypoxia-induced step change in deoxyhemoglobin
Dynamic susceptibility contrast (DSC) perfusion MRI measures blood flow metrics via application of a BOLD pulse sequence during transit of a gadolinium-based contrast agent (GBCA), We have previously shown that can also be performed using endogenous deoxyhemoglobin (dOHb) as a replacement for GBCA since dOHb also has the necessary paramagnetic properties similar to GBCA 1 . Conventional analysis with these contrast agents includes deconvolution of an arterial input function (AIF) assuming a kinetic model. However, the immediate decrease in dOHb that occurs during reoxygenation from a transient hypoxia constitutes a step reduction in susceptibility that permits direct, model-free, calculation of relative resting perfusion metrics. The metrics from this step analysis for seven healthy volunteers were compared to those from a conventional analysis of GBCA and dOHb. Voxel- wise maps of mean transit time, and relative cerebral blood flow and cerebral blood volume, had a high spatial congruence for all three analyses and were similar in appearance to published maps. The time course of the T2*-weighted signal step response identifies both the arrival time, the distribution of the step increase in arterial oxygen saturation, SaO 2 , and the voxel filling phase. The analysis of a step change in dOHb during rapid reoxygenation is an alternative way of calculating perfusion metrics directly from measurements of the resulting T2*-weighted signal, avoiding the potential errors from the use of a kinetic model and requirement for selection of an AIF.
Open AccessCerebral perfusion metrics calculated directly, model-free, from a hypoxia-induced step change in deoxyhemoglobin
Dynamic susceptibility contrast (DSC) perfusion MRI measures blood flow metrics via application of a BOLD pulse sequence during transit of a gadolinium-based contrast agent (GBCA), We have previously shown that can also be performed using endogenous deoxyhemoglobin (dOHb) as a replacement for GBCA since dOHb also has the necessary paramagnetic properties similar to GBCA 1 . Conventional analysis with these contrast agents includes deconvolution of an arterial input function (AIF) assuming a kinetic model. However, the immediate decrease in dOHb that occurs during reoxygenation from a transient hypoxia constitutes a step reduction in susceptibility that permits direct, model-free, calculation of relative resting perfusion metrics. The metrics from this step analysis for seven healthy volunteers were compared to those from a conventional analysis of GBCA and dOHb. Voxel- wise maps of mean transit time, and relative cerebral blood flow and cerebral blood volume, had a high spatial congruence for all three analyses and were similar in appearance to published maps. The time course of the T2*-weighted signal step response identifies both the arrival time, the distribution of the step increase in arterial oxygen saturation, SaO 2 , and the voxel filling phase. The analysis of a step change in dOHb during rapid reoxygenation is an alternative way of calculating perfusion metrics directly from measurements of the resulting T2*-weighted signal, avoiding the potential errors from the use of a kinetic model and requirement for selection of an AIF.
- Open Access
- 28 December 2023
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 45 (1) , 44-50
The Choroid Plexus as an Alternative Locus for the Identification of the Arterial Input Function for Calculating Cerebral Perfusion Metrics Using MRI
BACKGROUND AND PURPOSE: MR imaging–based cerebral perfusion metrics can be obtained by tracing the passage of a bolus of contrast through the microvasculature of the brain parenchyma. Thus, the temporal signal pattern of the contrast agent is typically measured over a large artery such as the MCA to generate the arterial input function. The largest intracranial arteries in the brain may not always be suitable for selecting the arterial input function due to skull base susceptibility artifacts or reduced size from steno-occlusive disease. Therefore, a suitable alternative arterial input function window would be useful. The choroid plexus is a highly vascular tissue composed essentially of arterialized blood vessels and acellular stroma with low metabolic requirements relative to its blood flow and may be a suitable alternative to identify the arterial input function. MATERIALS AND METHODS: We studied 8 healthy participants and 7 patients with gliomas who were administered a bolus of gadolinium. We selected an arterial input function from both the left and right M1 segments of the MCA and both lateral ventricles of the choroid plexus for each participant. We compared the changes in the T2* signal and the calculated resting perfusion metrics using the arterial input functions selected from the MCA and choroid plexus. RESULTS: We found no systematic difference between resting perfusion metrics in GM and WM when calculated using an arterial input function from the MCA or choroid plexus in the same participant. CONCLUSIONS: The choroid plexus provides an alternative location from which an arterial input function may be sampled when a suitable measure over an MCA is not available.
- 28 December 2023
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 45 (1) , 44-50
Open AccessThe Choroid Plexus as an Alternative Locus for the Identification of the Arterial Input Function for Calculating Cerebral Perfusion Metrics Using MRI
BACKGROUND AND PURPOSE: MR imaging–based cerebral perfusion metrics can be obtained by tracing the passage of a bolus of contrast through the microvasculature of the brain parenchyma. Thus, the temporal signal pattern of the contrast agent is typically measured over a large artery such as the MCA to generate the arterial input function. The largest intracranial arteries in the brain may not always be suitable for selecting the arterial input function due to skull base susceptibility artifacts or reduced size from steno-occlusive disease. Therefore, a suitable alternative arterial input function window would be useful. The choroid plexus is a highly vascular tissue composed essentially of arterialized blood vessels and acellular stroma with low metabolic requirements relative to its blood flow and may be a suitable alternative to identify the arterial input function. MATERIALS AND METHODS: We studied 8 healthy participants and 7 patients with gliomas who were administered a bolus of gadolinium. We selected an arterial input function from both the left and right M1 segments of the MCA and both lateral ventricles of the choroid plexus for each participant. We compared the changes in the T2* signal and the calculated resting perfusion metrics using the arterial input functions selected from the MCA and choroid plexus. RESULTS: We found no systematic difference between resting perfusion metrics in GM and WM when calculated using an arterial input function from the MCA or choroid plexus in the same participant. CONCLUSIONS: The choroid plexus provides an alternative location from which an arterial input function may be sampled when a suitable measure over an MCA is not available.
- Open Access
- 21 December 2023
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 45 (1) , 37-43
Assessing Perfusion in Steno-Occlusive Cerebrovascular Disease Using Transient Hypoxia-Induced Deoxyhemoglobin as a Dynamic Susceptibility Contrast Agent
BACKGROUND AND PURPOSE: Resting brain tissue perfusion in cerebral steno-occlusive vascular disease can be assessed by MR imaging using gadolinium-based susceptibility contrast agents. Recently, transient hypoxia-induced deoxyhemoglobin has been investigated as a noninvasive MR imaging contrast agent. Here we present a comparison of resting perfusion metrics using transient hypoxia-induced deoxyhemoglobin and gadolinium-based contrast agents in patients with known cerebrovascular steno-occlusive disease. MATERIALS AND METHODS: Twelve patients with steno-occlusive disease underwent DSC MR imaging using a standard bolus of gadolinium-based contrast agent compared with transient hypoxia-induced deoxyhemoglobin generated in the lungs using an automated gas blender. A conventional multi-slice 2D gradient echo sequence was used to acquire the perfusion data and analyzed using a standard tracer kinetic model. MTT, relative CBF, and relative CBV maps were generated and compared between contrast agents. RESULTS: The spatial distributions of the perfusion metrics generated with both contrast agents were consistent. Perfusion metrics in GM and WM were not statistically different except for WM MTT. CONCLUSIONS: Cerebral perfusion metrics generated with noninvasive transient hypoxia-induced changes in deoxyhemoglobin are very similar to those generated using a gadolinium-based contrast agent in patients with cerebrovascular steno-occlusive disease.
- 21 December 2023
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 45 (1) , 37-43
Open AccessAssessing Perfusion in Steno-Occlusive Cerebrovascular Disease Using Transient Hypoxia-Induced Deoxyhemoglobin as a Dynamic Susceptibility Contrast Agent
BACKGROUND AND PURPOSE: Resting brain tissue perfusion in cerebral steno-occlusive vascular disease can be assessed by MR imaging using gadolinium-based susceptibility contrast agents. Recently, transient hypoxia-induced deoxyhemoglobin has been investigated as a noninvasive MR imaging contrast agent. Here we present a comparison of resting perfusion metrics using transient hypoxia-induced deoxyhemoglobin and gadolinium-based contrast agents in patients with known cerebrovascular steno-occlusive disease. MATERIALS AND METHODS: Twelve patients with steno-occlusive disease underwent DSC MR imaging using a standard bolus of gadolinium-based contrast agent compared with transient hypoxia-induced deoxyhemoglobin generated in the lungs using an automated gas blender. A conventional multi-slice 2D gradient echo sequence was used to acquire the perfusion data and analyzed using a standard tracer kinetic model. MTT, relative CBF, and relative CBV maps were generated and compared between contrast agents. RESULTS: The spatial distributions of the perfusion metrics generated with both contrast agents were consistent. Perfusion metrics in GM and WM were not statistically different except for WM MTT. CONCLUSIONS: Cerebral perfusion metrics generated with noninvasive transient hypoxia-induced changes in deoxyhemoglobin are very similar to those generated using a gadolinium-based contrast agent in patients with cerebrovascular steno-occlusive disease.
- Open Access
- 8 August 2023
- Published by MDPI AG in Healthcare
- Vol. 11 (16) , 2231
Convolutional Neural Networks to Assess Steno-Occlusive Disease Using Cerebrovascular Reactivity
Cerebrovascular Reactivity (CVR) is a provocative test used with Blood oxygenation level-dependent (BOLD) Magnetic Resonance Imaging (MRI) studies, where a vasoactive stimulus is applied and the corresponding changes in the cerebral blood flow (CBF) are measured. The most common clinical application is the assessment of cerebral perfusion insufficiency in patients with steno-occlusive disease (SOD). Globally, millions of people suffer from cerebrovascular diseases, and SOD is the most common cause of ischemic stroke. Therefore, CVR analyses can play a vital role in early diagnosis and guiding clinical treatment. This study develops a convolutional neural network (CNN)-based clinical decision support system to facilitate the screening of SOD patients by discriminating between healthy and unhealthy CVR maps. The networks were trained on a confidential CVR dataset with two classes: 68 healthy control subjects, and 163 SOD patients. This original dataset was distributed in a ratio of 80%-10%-10% for training, validation, and testing, respectively, and image augmentations were applied to the training and validation sets. Additionally, some popular pre-trained networks were imported and customized for the objective classification task to conduct transfer learning experiments. Results indicate that a customized CNN with a double-stacked convolution layer architecture produces the best results, consistent with expert clinical readings.
- 8 August 2023
- Published by MDPI AG in Healthcare
- Vol. 11 (16) , 2231
Open AccessConvolutional Neural Networks to Assess Steno-Occlusive Disease Using Cerebrovascular Reactivity
Cerebrovascular Reactivity (CVR) is a provocative test used with Blood oxygenation level-dependent (BOLD) Magnetic Resonance Imaging (MRI) studies, where a vasoactive stimulus is applied and the corresponding changes in the cerebral blood flow (CBF) are measured. The most common clinical application is the assessment of cerebral perfusion insufficiency in patients with steno-occlusive disease (SOD). Globally, millions of people suffer from cerebrovascular diseases, and SOD is the most common cause of ischemic stroke. Therefore, CVR analyses can play a vital role in early diagnosis and guiding clinical treatment. This study develops a convolutional neural network (CNN)-based clinical decision support system to facilitate the screening of SOD patients by discriminating between healthy and unhealthy CVR maps. The networks were trained on a confidential CVR dataset with two classes: 68 healthy control subjects, and 163 SOD patients. This original dataset was distributed in a ratio of 80%-10%-10% for training, validation, and testing, respectively, and image augmentations were applied to the training and validation sets. Additionally, some popular pre-trained networks were imported and customized for the objective classification task to conduct transfer learning experiments. Results indicate that a customized CNN with a double-stacked convolution layer architecture produces the best results, consistent with expert clinical readings.
- Open Access
- 29 October 2022
- Published by Wiley in Human Brain Mapping
- Vol. 44 (3) , 1019-1029
Investigations of hypoxia‐induced deoxyhemoglobin as a contrast agent for cerebral perfusion imaging
The assessment of resting perfusion measures (mean transit time, cerebral blood flow, and cerebral blood volume) with magnetic resonance imaging currently requires the presence of a susceptibility contrast agent such as gadolinium. Here, we present an initial comparison between perfusion measures obtained using hypoxia‐induced deoxyhemoglobin and gadolinium in healthy study participants. We hypothesize that resting cerebral perfusion measures obtained using precise changes of deoxyhemoglobin concentration will generate images comparable to those obtained using a clinical standard, gadolinium. Eight healthy study participants were recruited (6F; age 23–60). The study was performed using a 3‐Tesla scanner with an eight‐channel head coil. The experimental protocol consisted of a high‐resolution T1‐weighted scan followed by two BOLD sequence scans in which each participant underwent a controlled bolus of transient pulmonary hypoxia, and subsequently received an intravenous bolus of gadolinium. The resting perfusion measures calculated using hypoxia‐induced deoxyhemoglobin and gadolinium yielded maps that looked spatially comparable. There was no statistical difference between methods in the average voxel‐wise measures of mean transit time, relative cerebral blood flow and relative cerebral blood volume, in the gray matter or white matter within each participant. We conclude that perfusion measures generated with hypoxia‐induced deoxyhemoglobin are spatially and quantitatively comparable to those generated from a gadolinium injection in the same healthy participant.
- 29 October 2022
- Published by Wiley in Human Brain Mapping
- Vol. 44 (3) , 1019-1029
Open AccessInvestigations of hypoxia‐induced deoxyhemoglobin as a contrast agent for cerebral perfusion imaging
The assessment of resting perfusion measures (mean transit time, cerebral blood flow, and cerebral blood volume) with magnetic resonance imaging currently requires the presence of a susceptibility contrast agent such as gadolinium. Here, we present an initial comparison between perfusion measures obtained using hypoxia‐induced deoxyhemoglobin and gadolinium in healthy study participants. We hypothesize that resting cerebral perfusion measures obtained using precise changes of deoxyhemoglobin concentration will generate images comparable to those obtained using a clinical standard, gadolinium. Eight healthy study participants were recruited (6F; age 23–60). The study was performed using a 3‐Tesla scanner with an eight‐channel head coil. The experimental protocol consisted of a high‐resolution T1‐weighted scan followed by two BOLD sequence scans in which each participant underwent a controlled bolus of transient pulmonary hypoxia, and subsequently received an intravenous bolus of gadolinium. The resting perfusion measures calculated using hypoxia‐induced deoxyhemoglobin and gadolinium yielded maps that looked spatially comparable. There was no statistical difference between methods in the average voxel‐wise measures of mean transit time, relative cerebral blood flow and relative cerebral blood volume, in the gray matter or white matter within each participant. We conclude that perfusion measures generated with hypoxia‐induced deoxyhemoglobin are spatially and quantitatively comparable to those generated from a gadolinium injection in the same healthy participant.
- 1 July 2022
- Published by Wolters Kluwer Health in Stroke
- Vol. 53 (7) , E251-E252
Detecting Silent Acute Microinfarcts in Cerebral Small Vessel Disease Using Submillimeter Diffusion-Weighted Magnetic Resonance Imaging: Preliminary Results
- 1 July 2022
- Published by Wolters Kluwer Health in Stroke
- Vol. 53 (7) , E251-E252
Detecting Silent Acute Microinfarcts in Cerebral Small Vessel Disease Using Submillimeter Diffusion-Weighted Magnetic Resonance Imaging: Preliminary Results
- 5 April 2022
- Published by Wolters Kluwer Health in Neurology
- Vol. 98 (14) , e1446-e1458
Association of Iatrogenic Infarcts With Clinical and Cognitive Outcomes in the Evaluating Neuroprotection in Aneurysm Coiling Therapy Trial
Background and Objectives Small iatrogenic brain infarcts are often seen on diffusion-weighted MRI (DWI) following surgical or endovascular procedures, but there are few data on their clinical effects. We examined the association of iatrogenic infarcts with outcomes in the ENACT (Evaluating Neuroprotection in Aneurysm Coiling Therapy) randomized controlled trial of nerinetide in patients undergoing endovascular repair of intracranial aneurysms. Methods In this post hoc analysis, we used multivariable models to evaluate the association of the presence and number of iatrogenic infarcts on DWI with neurologic impairment (NIH Stroke Scale [NIHSS]), functional status (modified Rankin Scale [mRS]), and cognitive and neuropsychiatric outcomes (30-minute test battery) at 1–4 days and 30 days postprocedure. We also related infarct number to a z score–derived composite outcome score using quantile regression. Results Among 184 patients (median age 56 years [interquartile range (IQR) 50–64]), 124 (67.4%) had postprocedural DWI lesions (median 4, IQR 2–10.5). Nerinetide treatment was associated with fewer iatrogenic infarcts but no overall significant clinical treatment effects. Patients with infarcts had lower Mini-Mental State Examination (MMSE) scores at 2–4 days (median 28 vs 29, adjusted coefficient [acoef] −1.11, 95% CI −1.88 to −0.34, p = 0.005). Higher lesion counts were associated with worse day 1 NIHSS (adjusted odds ratio for NIHSS ≥1: 1.07, 1.02–1.12, p = 0.009), day 2–4 mRS (adjusted common odds ratio [acOR] 1.05, 1.01–1.09, p = 0.005), and day 2–4 MMSE (acoef −0.07, −0.13 to −0.003, p = 0.040) scores. At 30 days, infarct number remained associated with worse mRS (acOR 1.04, 1.01–1.07, p = 0.016) and Hopkins Verbal Learning Test (HVLT) delayed recall scores (acoef −0.21, −0.39 to −0.03, p = 0.020). Patients with infarcts trended towards lower 30-day Digit Symbol Substitution Test (DSST) scores (acoef −3.73, −7.36 to −0.10, p = 0.044). Higher lesion count was associated with worse composite outcome scores at both 1–4 days and 30 days (30-day acoef −0.12, 95% CI −0.21 to −0.03, p = 0.008). Among those with infarcts, day 1 NIHSS and day 2–4 mRS correlated with 30-day NIHSS, DSST, HVLT, and mRS scores, whereas day 2–4 MMSE correlated with 30-day NIHSS and DSST scores (Spearman ρ 0.47, p = 0.001). Discussion Iatrogenic brain infarcts were associated with subtle differences in postprocedural (1–4 days) and 30-day outcomes on different measures in this middle-aged cohort, with earlier dysfunction correlating with later differences. Trial Registration Information Clinical trials registration NCT00728182.
- 5 April 2022
- Published by Wolters Kluwer Health in Neurology
- Vol. 98 (14) , e1446-e1458
Association of Iatrogenic Infarcts With Clinical and Cognitive Outcomes in the Evaluating Neuroprotection in Aneurysm Coiling Therapy Trial
Background and Objectives Small iatrogenic brain infarcts are often seen on diffusion-weighted MRI (DWI) following surgical or endovascular procedures, but there are few data on their clinical effects. We examined the association of iatrogenic infarcts with outcomes in the ENACT (Evaluating Neuroprotection in Aneurysm Coiling Therapy) randomized controlled trial of nerinetide in patients undergoing endovascular repair of intracranial aneurysms. Methods In this post hoc analysis, we used multivariable models to evaluate the association of the presence and number of iatrogenic infarcts on DWI with neurologic impairment (NIH Stroke Scale [NIHSS]), functional status (modified Rankin Scale [mRS]), and cognitive and neuropsychiatric outcomes (30-minute test battery) at 1–4 days and 30 days postprocedure. We also related infarct number to a z score–derived composite outcome score using quantile regression. Results Among 184 patients (median age 56 years [interquartile range (IQR) 50–64]), 124 (67.4%) had postprocedural DWI lesions (median 4, IQR 2–10.5). Nerinetide treatment was associated with fewer iatrogenic infarcts but no overall significant clinical treatment effects. Patients with infarcts had lower Mini-Mental State Examination (MMSE) scores at 2–4 days (median 28 vs 29, adjusted coefficient [acoef] −1.11, 95% CI −1.88 to −0.34, p = 0.005). Higher lesion counts were associated with worse day 1 NIHSS (adjusted odds ratio for NIHSS ≥1: 1.07, 1.02–1.12, p = 0.009), day 2–4 mRS (adjusted common odds ratio [acOR] 1.05, 1.01–1.09, p = 0.005), and day 2–4 MMSE (acoef −0.07, −0.13 to −0.003, p = 0.040) scores. At 30 days, infarct number remained associated with worse mRS (acOR 1.04, 1.01–1.07, p = 0.016) and Hopkins Verbal Learning Test (HVLT) delayed recall scores (acoef −0.21, −0.39 to −0.03, p = 0.020). Patients with infarcts trended towards lower 30-day Digit Symbol Substitution Test (DSST) scores (acoef −3.73, −7.36 to −0.10, p = 0.044). Higher lesion count was associated with worse composite outcome scores at both 1–4 days and 30 days (30-day acoef −0.12, 95% CI −0.21 to −0.03, p = 0.008). Among those with infarcts, day 1 NIHSS and day 2–4 mRS correlated with 30-day NIHSS, DSST, HVLT, and mRS scores, whereas day 2–4 MMSE correlated with 30-day NIHSS and DSST scores (Spearman ρ 0.47, p = 0.001). Discussion Iatrogenic brain infarcts were associated with subtle differences in postprocedural (1–4 days) and 30-day outcomes on different measures in this middle-aged cohort, with earlier dysfunction correlating with later differences. Trial Registration Information Clinical trials registration NCT00728182.
- Open Access
Quantifying cerebral blood arrival times using hypoxia-mediated arterial BOLD contrast
Cerebral blood arrival and tissue transit times are sensitive measures of the efficiency of tissue perfusion and can provide clinically meaningful information on collateral blood flow status. We exploit the arterial blood oxygen level dependent (BOLD) signal contrast established by precisely modulating arterial hemoglobin saturation using hypoxic respiratory challenges (dOHb-BOLD) to quantify arterial blood arrival times throughout the brain. A combination of hemodynamic lag with a modified carpet plot analysis yielded lag, onset (blood arrival), mean transit time (MTT) and hypoxic response information, which is indicative of relative total blood volume. Onset times averaged across 12 healthy subjects were 1.1 ± 0.4 and 1.9 ± 0.6 for cortical gray and deep white matter, respectively. The average whole brain MTT was 4.5 ± 0.9 seconds. The dOHb-BOLD response was 1.7 fold higher in grey versus white; in line with known differences in regional blood volume fraction. Our method was also applied in unilateral carotid artery occlusion patient, which revealed prolonged signal onset with normal perfusion in the affected hemisphere. In cases with exhausted reserve capacity or confounding flow effects such as vascular steal, dOHb-BOLD can potentially inform on collateral flow pathways to provide a valuable compliment to clinical vascular reactivity measures.
Open AccessQuantifying cerebral blood arrival times using hypoxia-mediated arterial BOLD contrast
Cerebral blood arrival and tissue transit times are sensitive measures of the efficiency of tissue perfusion and can provide clinically meaningful information on collateral blood flow status. We exploit the arterial blood oxygen level dependent (BOLD) signal contrast established by precisely modulating arterial hemoglobin saturation using hypoxic respiratory challenges (dOHb-BOLD) to quantify arterial blood arrival times throughout the brain. A combination of hemodynamic lag with a modified carpet plot analysis yielded lag, onset (blood arrival), mean transit time (MTT) and hypoxic response information, which is indicative of relative total blood volume. Onset times averaged across 12 healthy subjects were 1.1 ± 0.4 and 1.9 ± 0.6 for cortical gray and deep white matter, respectively. The average whole brain MTT was 4.5 ± 0.9 seconds. The dOHb-BOLD response was 1.7 fold higher in grey versus white; in line with known differences in regional blood volume fraction. Our method was also applied in unilateral carotid artery occlusion patient, which revealed prolonged signal onset with normal perfusion in the affected hemisphere. In cases with exhausted reserve capacity or confounding flow effects such as vascular steal, dOHb-BOLD can potentially inform on collateral flow pathways to provide a valuable compliment to clinical vascular reactivity measures.